NCT07579182 Hormones, Outcomes, and Pain Pathways in Exercise Study
| NCT ID | NCT07579182 |
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | University of Houston |
| Condition | Breast Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2026-05-17 |
| Primary Completion | 2029-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 140 participants in total. It began in 2026-05-17 with a primary completion date of 2029-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the proposed project is to evaluate a mechanical intervention (sports bras designed specifically for full busted women) to alleviate neck, shoulder, arm, and back pain in full-busted women and investigate the contribution of non-mechanical pathways associated with this type of pain in women. Specifically, the investigators will investigate how sex-hormones, inflammation, and remapping of specific regions of the brain contribute to the manifestation of neck, shoulder, arm, and back pain in full-busted women across the lifespan.
Eligibility Criteria
Inclusion Criteria: 1. Able to provide informed consent 2. Age of 18 to 60 years 3. Assigned female sex at birth 4. Right-handed by self-declaration 5. Willing to participate in one online testing session and up to four in-person testing sessions 6. Bra band size between 32-40" 7. International Physical Activity Questionnaire - Short Form (IPAQ-SF) score of 2 or higher 8. An answer of "NO" to any item of the general health questions of the PARQ+ 9. No history of surgery to the: back, neck, or shoulders or joint replacement 10. No history of implanted pacemakers or other stimulation devices 11. No history of spinal cord injury (SCI) Exclusion Criteria: 1. Inability to provide informed consent 2. Age 17 years old or younger or 61 years or older 3. Assigned male sex at birth 4. Left-handed by self-declaration 5. Not willing to participate in one online testing session and up to four in-person testing sessions 6. Bra band size greater than 40" or less than 32" 7. IPAQ-SF score of 1 or lower 8. An answer of "YES" to any item of the general health questions of the PARQ+ 9. History of limb amputation (upper or lower extremity) 10. Presence of open pressure sores on the upper or lower extremities 11. Currently pregnant or lactating/breastfeeding 12. History of surgery to the: back, neck, or shoulders or joint replacement 13. History of breast cancer and/or mastectomy 14. History of implanted pacemakers or other stimulation devices 15. History of spinal cord injury (SCI) 16. History of joint disease including osteoarthritis and/or Rheumatoid Arthritis 17. History of the following neurological diseases: Cerebrovascular accident (CVA, stroke), Alzheimer's Disease (AD), Dementia (of any form), Huntington's Disease, Traumatic Brain Injury (TBI), Spinal cord injury (SCI), Multiple Sclerosis (MS), Parkinson's Disease (PD), Polio, Paraproteinaemic Demyelinating Neuropathy (PDN) and/or Monoclonal Gammopathy of Undetermined Significance (MGUS), Myasthenia Gravis, Muscular Dystrophy, Guillain-Barré Syndrome, Scoliosis, Charcot-Marie-Tooth Disorder or other hereditary neuropathies Additional Inclusion Criteria for Intervention Group: a. Self-declared breast size of D-I cup (US sizes: D, E, F, G, H) Additional Inclusion Criteria for the Control Group: a. Self-declared breast size of A-C cup (US sizes: AA, A, B, C)
Contact & Investigator
Stacey L Gorniak, PhD
PRINCIPAL INVESTIGATOR
University of Houston
Frequently Asked Questions
Who can join the NCT07579182 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 60 Years, studying Breast Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07579182 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT07579182 currently recruiting?
Yes, NCT07579182 is actively recruiting participants. Contact the research team at sgorniak@uh.edu for enrollment information.
Where is the NCT07579182 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07579182 clinical trial?
NCT07579182 is sponsored by University of Houston. The principal investigator is Stacey L Gorniak, PhD at University of Houston. The trial plans to enroll 140 participants.